Study looks at effects of low-, high-dose statins on diabetes

04/24/2012 | Medscape (free registration)

Patients who were on high-dose statin treatment did not appear to have a higher risk of developing new-onset diabetes compared with their counterparts who were on low-/moderate-dose statin therapy, an analysis found. Larger prospective studies are needed to examine the risks and benefits of long-term statin use in people at high risk of diabetes, the study's lead author said. The results were presented at the World Congress of Cardiology 2012.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA